BRIEF-GW Pharma Announces Acceptance Of NDA Filing For Epidiolex (Cannabidiol)
December 28, 2017 at 07:04 AM EST
* GW PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF NDA FILING FOR EPIDIOLEX® (CANNABIDIOL) IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME AND DRAVET SYNDROME Source text for Eikon: Further company coverage: